Schonfeld Strategic Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
1,871
-58,504
| -97% | -$10.1M | ﹤0.01% | 1582 |
|
|
2025
Q1 | $9.41M | Sell |
60,375
-78,218
| -56% | -$12.2M | 0.06% | 303 |
|
|
2024
Q4 | $19.1M | Sell |
138,593
-89,932
| -39% | -$12.4M | 0.11% | 149 |
|
|
2024
Q3 | $34.1M | Buy |
228,525
+130,384
| +133% | +$19.5M | 0.23% | 45 |
|
|
2024
Q2 | $13.4M | Sell |
98,141
-3,859
| -4% | -$526K | 0.09% | 235 |
|
|
2024
Q1 | $15.4M | Sell |
102,000
-22,901
| -18% | -$3.46M | 0.1% | 212 |
|
|
2023
Q4 | $15.7M | Buy |
124,901
+86,001
| +221% | +$10.8M | 0.1% | 202 |
|
|
2023
Q3 | $3.64M | Buy |
38,900
+7,700
| +25% | +$721K | 0.03% | 546 |
|
|
2023
Q2 | $2.78M | Buy |
31,200
+10,300
| +49% | +$919K | 0.02% | 648 |
|
|
2023
Q1 | $2.24M | Sell |
20,900
-46,958
| -69% | -$5.03M | 0.02% | 658 |
|
|
2022
Q4 | $8.29M | Buy |
67,858
+52,358
| +338% | +$6.39M | 0.07% | 347 |
|
|
2022
Q3 | $1.6M | Buy |
+15,500
| New | +$1.6M | 0.01% | 972 |
|
|
2022
Q1 | – | Sell |
-12,800
| Closed | -$1.72M | – | 2373 |
|
|
2021
Q4 | $1.72M | Buy |
+12,800
| New | +$1.72M | 0.02% | 687 |
|
|
2021
Q3 | – | Sell |
-13,900
| Closed | -$1.83M | – | 1985 |
|
|
2021
Q2 | $1.83M | Buy |
13,900
+5,800
| +72% | +$763K | 0.02% | 710 |
|
|
2021
Q1 | $1.04M | Sell |
8,100
-16,520
| -67% | -$2.13M | 0.01% | 838 |
|
|
2020
Q4 | $4.11M | Sell |
24,620
-3,295
| -12% | -$550K | 0.06% | 418 |
|
|
2020
Q3 | $4.31M | Buy |
27,915
+13,415
| +93% | +$2.07M | 0.08% | 306 |
|
|
2020
Q2 | $2.14M | Buy |
+14,500
| New | +$2.14M | 0.06% | 363 |
|
|
2020
Q1 | – | Sell |
-11,400
| Closed | -$1.59M | – | 1131 |
|
|
2019
Q4 | $1.59M | Sell |
11,400
-28,400
| -71% | -$3.95M | 0.04% | 386 |
|
|
2019
Q3 | $3.83M | Sell |
39,800
-51,700
| -57% | -$4.98M | 0.11% | 200 |
|
|
2019
Q2 | $10.5M | Sell |
91,500
-92,900
| -50% | -$10.7M | 0.37% | 64 |
|
|
2019
Q1 | $21.7M | Buy |
+184,400
| New | +$21.7M | 0.75% | 16 |
|
|
2018
Q3 | – | Sell |
-15,000
| Closed | -$997K | – | 780 |
|
|
2018
Q2 | $997K | Buy |
+15,000
| New | +$997K | 0.05% | 392 |
|
|
2017
Q4 | – | Sell |
-9,763
| Closed | -$354K | – | 718 |
|
|
2017
Q3 | $354K | Buy |
+9,763
| New | +$354K | 0.03% | 428 |
|